Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MIND GamePack: A novel digital health technology for assessment of participants with and without cognitive impairment.

The journal of prevention of Alzheimer's disease·2026
Same author

Changes in conversational pattern as a clinical trial outcome: a proof-of-concept study using the I-CONECT data.

Innovation in aging·2026
Same author

How loneliness and social isolation are linked to cognitive decline among older adults? A systematic review of underlying physiological and psychobehavioral mechanisms.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias.

Neurology·2026
Same author

Detecting cognitive impairment and psychological well-being among older adults.

Machine learning. Health·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Jan 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Longitudinal methods for Alzheimer's cognitive status prediction with deep learning.

Houjun Liu1, Alyssa Mae Weakley2, Hiroko H Dodge3

  • 1Computer Science, Stanford University, Stanford, California, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|September 25, 2025
PubMed
Summary

This study introduces a novel deep learning method for predicting cognitive decline over 3-10 years. The new technique shows improved accuracy in forecasting amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) progression.

Keywords:
Alzheimer's Disease Research CentersAlzheimer's dementiaNational Alzheimer's Coordinating Centerdata sciencedeep learningmachine learningmild cognitive impairmenttransformers

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.4K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.7K

Related Experiment Videos

Last Updated: Jan 17, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.4K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.7K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Biostatistics

Background:

  • Machine learning for cognitive decline prediction typically focuses on short-term (1-3 years) forecasting.
  • Long-term prediction (3-10 years) of cognitive status remains a significant challenge in dementia research.

Purpose of the Study:

  • To develop and validate a novel deep learning technique for extending the prediction horizon of cognitive status.
  • To improve the accuracy of predicting amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) over a 3- to 10-year period.

Main Methods:

  • Leveraged deep learning on longitudinal neuropsychological data and patient history.
  • Introduced techniques to separate baseline features and deviations, and a linear attention-based imputation method.

Main Results:

  • Achieved high prediction accuracy: 81.65% for Control, 72.87% for aMCI, and 86.52% for AD over a 3- to 10-year horizon.
  • The new method outperformed previous approaches for long-term cognitive status prediction.

Conclusions:

  • Presents a novel set of deep learning techniques for analyzing longitudinal dementia data.
  • Highlights the feasibility and improved accuracy of long-term prediction for aMCI and AD, even for cases progressing to AD.